| 000 | 02637 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250517120805.0 | ||
| 264 | 0 | _c20180223 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.12428 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKashyap, Trinayan | |
| 245 | 0 | 0 |
_aSelinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death. _h[electronic resource] |
| 260 |
_bOncotarget _cNov 2016 |
||
| 300 |
_a78883-78895 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aActive Transport, Cell Nucleus _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBortezomib _xpharmacology |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Nucleus _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrazines _xpharmacology |
| 650 | 0 | 4 |
_aKaryopherins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aNF-KappaB Inhibitor alpha _xgenetics |
| 650 | 0 | 4 |
_aNF-kappa B _xgenetics |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xmetabolism |
| 650 | 0 | 4 |
_aProteasome Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProteolysis |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTranscription Factor RelA _xgenetics |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 650 | 0 | 4 | _aExportin 1 Protein |
| 700 | 1 | _aArgueta, Christian | |
| 700 | 1 | _aAboukameel, Amro | |
| 700 | 1 | _aUnger, Thaddeus John | |
| 700 | 1 | _aKlebanov, Boris | |
| 700 | 1 | _aMohammad, Ramzi M | |
| 700 | 1 | _aMuqbil, Irfana | |
| 700 | 1 | _aAzmi, Asfar S | |
| 700 | 1 | _aDrolen, Claire | |
| 700 | 1 | _aSenapedis, William | |
| 700 | 1 | _aLee, Margaret | |
| 700 | 1 | _aKauffman, Michael | |
| 700 | 1 | _aShacham, Sharon | |
| 700 | 1 | _aLandesman, Yosef | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 48 _gp. 78883-78895 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.12428 _zAvailable from publisher's website |
| 999 |
_c26492337 _d26492337 |
||